FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder
TechCrunch
BioticsAI CEO Robhy Bustami shares insights on navigating FDA regulations and maintaining team motivation while building healthcare technology.Summary
Robhy Bustami, CEO of BioticsAI, discusses the challenges of building in the healthcare sector, where rigorous processes and regulatory compliance take precedence over speed. By integrating clinical validation and regulatory strategy into early development, the company successfully secured FDA approval for its AI-powered fetal ultrasound diagnostic tool. Bustami emphasizes that transparent engagement with regulators and maintaining strong team alignment throughout long development cycles are critical for success in the medical device industry.
(Source：TechCrunch)